Stay Awake (Caffeine)
Brand Names: Stay Awake
Methodology & AI Transparency ⓘ
Stay Awake (Caffeine) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Stay Awake (Caffeine) represents a over-the-counter branded central nervous system stimulant entry registered by United Natural Foods, Inc.
- 2 Real-world patient consensus: Branded central nervous system stimulant presentation of Caffeine (United Natural Foods, Inc. dba UNFI); generic reference: /meds/caffeine.
- 3 Typical cash cost range: Uninsured 30-day outlay compares $14.82 cash mean against $39.27 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Stay Awake (Caffeine) tolerability events: fatigue (7.6%), somnolence (8.5%), nausea (7.7%).
Ask our AI Specialists anything about Stay Awake (Caffeine)
Stay Awake (Caffeine) Mechanism, CYP450 Pathways & DailyMed Monograph
Stay Awake (Caffeine) represents a over-the-counter branded central nervous system stimulant entry registered by United Natural Foods, Inc. dba UNFI with package codes 41163-226, 30142-284. Reviewed against 2026-08-21 FDA SPL standards (200 mg/1 Tablet; 200 mg/1 Tablet, Coated), clinical deployment addresses Use helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness
Stay Awake achieves therapeutic action via Caffeine, engaging central nervous system stimulant physiological pathways with class-characteristic hepatorenal disposition. Manufactured in 200 mg/1 Tablet; 200 mg/1 Tablet, Coated (registered by United Natural Foods, Inc. dba UNFI, NDC 41163-226, 30142-284), pharmacists evaluate FDA Orange Book therapeutic equivalence when comparing branded Stay Awake ($39.27 retail) with generic Caffeine ($14.82 low cash).
Systemic exposure to Stay Awake (Caffeine) reflects Approximately 73% to 85% enteral uptake across labeled Stay Awake (Caffeine) strengths absorption kinetics and predominantly hepatic biotransformation with renal elimination of polar stay awake (caffeine) conjugates, sustaining receptor engagement across a Steady-state plasma equilibrium reached over 3–12 hour t½ intervals for Stay Awake (Caffeine) half-life window (maximum serum exposure occurs 2–5 hours after stay awake (caffeine) dosing response profile).
Dosing protocols (200 mg/1 Tablet or 200 mg/1 Tablet, Coated or 200 mg/1 Tablet, Film Coated) balance efficacy (74.00% patient satisfaction across 16 logs) against somnolence (8.5% of reports), headache (7.8% of reports), nausea (7.7% of reports), with strict avoidance in contraindicated in patients with prior serious allergic response to stay awake (caffeine) (ndc 41163-226); severe baseline organ impairment where caffeine accumulation exceeds safe therapeutic margins.
Reconcile eGFR-adjusted medications before escalating Stay Awake (Caffeine) in polypharmacy regimens.
Unstandardized herbal extracts may interact pharmacodynamically with Stay Awake (Caffeine) maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Contraindicated in patients with prior serious allergic response to Stay Awake (Caffeine) (NDC 41163-226)
- Severe baseline organ impairment where Caffeine accumulation exceeds safe therapeutic margins
Logged Side-Effect Incidence (16 Reports)
Stay Awake (Caffeine) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Stay Awake (Caffeine))
Human clinical trial evidence for Stay Awake (Caffeine) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Stay Awake (Caffeine) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0877/unit (~$2.63/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $39.27 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 16 Anonymous DotMD Community Micro-Logs | $14.82 / mo | View logs ↓ |
| AgelessRx Geroprotective Telehealth (Licensed Telehealth Cash Program) | State-licensed clinician review • ~3d mail fulfillment | $65.00/mo program | Program details |
Stay Awake (Caffeine) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Stay Awake (Caffeine) RxNorm Concept ID | 198520 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0877 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $39.27 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $14.82 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 74.00% Worth It (16 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Stay Awake (Caffeine) Patient Community, Cohort Filters & Dosage Logs
Cross-verified Stay Awake (Caffeine) (central nervous system stimulant) monograph synthesizing RxNorm 198520, openFDA FAERS signals, and $14.82–$39.27 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Stay Awake (Caffeine) community threads and patient logs by age, biological sex, dosage, and treatment duration.